Compound 549
Identifiers
- Canonical SMILES:
CCn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)cc2)c1=O
- InChi:
InChI=1S/C22H15F4N5O/c1-2-30-20-16(11-27-30)19-17(21(32)31(29-19)15-8-6-14(23)7-9-15)18(28-20)12-4-3-5-13(10-12)22(24,25)26/h3-11,29H,2H2,1H3
- InChiKey:
OEHLCEZIJXZOBM-UHFFFAOYSA-N
External links
168318171 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 5.82 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 441.12 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 5.49 | |||
TPSA | 63.05 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4936 | Riociguat | DB08931 | |
0.4798 | ATX-914 | DB12673 | |
0.4774 | Vericiguat | DB15456 | |
0.4748 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4589 | Tepotinib | DB15133 | |
0.4564 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4537 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4528 | MK-0249 | DB11910 | |
0.4489 | Decoglurant | DB11923 | |
0.4483 | Dilmapimod | DB12140 | |
0.4436 | Risdiplam | DB15305 | |
0.4435 | Ravoxertinib | DB15281 | |
0.4331 | Merestinib | DB12381 | |
0.4323 | CVT-6883 | DB05936 | |
0.4310 | Neflamapimod | DB07138 |